Medical News

RSS
First Edition: June 4, 2012

First Edition: June 4, 2012

ShangPharma celebrates 10th anniversary of partnership with Lilly

ShangPharma celebrates 10th anniversary of partnership with Lilly

Advaxis to update preliminary data on ADXS-HPV Phase 2 trial for cervical cancer

Advaxis to update preliminary data on ADXS-HPV Phase 2 trial for cervical cancer

Prisoners need education on the appropriate use of topical antibiotic products

Prisoners need education on the appropriate use of topical antibiotic products

Exelixis reports positive interim data from cabozantinib phase 2 trial on HCC

Exelixis reports positive interim data from cabozantinib phase 2 trial on HCC

New group-based learning approach for children with asthma

New group-based learning approach for children with asthma

Regular and moderate exercise most beneficial for cardiovascular health

Regular and moderate exercise most beneficial for cardiovascular health

Onyx announces data from regorafenib Phase 3 trial on GIST

Onyx announces data from regorafenib Phase 3 trial on GIST

MitrAssist receives ISO certification for design and development of mitral valve prosthesis

MitrAssist receives ISO certification for design and development of mitral valve prosthesis

Oncothyreon announces data from two clinical trials of PX-866 at ASCO meeting

Oncothyreon announces data from two clinical trials of PX-866 at ASCO meeting

MARIJUANA announces corporate name change to Hemp

MARIJUANA announces corporate name change to Hemp

New data from ImmunoGen’s SAR3419 Phase I study on CD19+ NHL

New data from ImmunoGen’s SAR3419 Phase I study on CD19+ NHL

High levels of antibody molecule linked to increased rates of death from all diseases

High levels of antibody molecule linked to increased rates of death from all diseases

New data from OncoMed’s OMP-59R5 Phase I study on advanced solid tumors

New data from OncoMed’s OMP-59R5 Phase I study on advanced solid tumors

CTI acquires world-wide rights to S*BIO’s pacritinib

CTI acquires world-wide rights to S*BIO’s pacritinib

ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast cancer

ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast cancer

Many men with metastatic prostate cancer live longer on continuous hormone therapy

Many men with metastatic prostate cancer live longer on continuous hormone therapy

Positive results from Auxilium’s XIAFLEX phase III studies on Peyronie's disease

Positive results from Auxilium’s XIAFLEX phase III studies on Peyronie's disease

Study shows valuable role of Mammostrat in assessing ER+ postmenopausal breast cancer patients

Study shows valuable role of Mammostrat in assessing ER+ postmenopausal breast cancer patients

Duloxetine drug reduces painful chemotherapy-induced peripheral neuropathy in majority of patients

Duloxetine drug reduces painful chemotherapy-induced peripheral neuropathy in majority of patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.